Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Different hair protein amounts change the strength of keratin/chitosan gels, useful for making predictable tissue engineering materials.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

FUE provides minimal scarring and quick recovery in hair transplantation, and surgeons not using it may lag in technology.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Growing hair follicles have high mitochondrial activity and ROS in specific regions, aiding hair formation.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Androgens may block hair growth signals, targeting this could treat hair loss.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

GLI2 increases follistatin production in human skin cells.

Minoxidil lowers blood pressure, increases heart rate, and improves blood flow in dogs.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.